Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Merck & Company Static Chart

Rise of
+0.15 (+1.00%) Merck & Company - [Ticker: MRK]Chart Merck & Company  News Merck & Company  Download Historical Prices for Metastock Merck & Company and Others  Technical Analysis Merck & Company  
Last Trade79.37Last Trade Time2018-12-04 - 00:00:00
Variation+0.15 (+1.00%)Open79.30
Volume4,330,639Average Volume (3m)0
YieldBid / Ask55.43 x 900 - 55.44 x 2,100
Former Close79.2252 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Merck & Company [MRK]:   (ordered by relevance)
  1. Merck's Covid pill secures narrow backing from US regulatory panel  Financial Times
  2. Merck says its COVID-19 drug should be effective against any variant  Reuters
  3. Merck?s COVID-19 pill may soon be here. How well will it work?  Science News
  4. Merck?s Covid Treatment Pill Wins Blessing of F.D.A. Panel  The New York Times
  5. What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?  Forbes
  1. Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?  Forbes
  2. Why Merck Stock Is Slipping Today  The Motley Fool
  3. Merck stock dives after Citi downgrades on 'high probability' that HIV treatment will be abandoned  MarketWatch
  4. Merck Stock Is A Strong Buy On The Drop (NYSE:MRK)  Seeking Alpha
Why molnupiravir could still work for Merck  Vantage South Africa in Talks With Pfizer, Merck for Covid Pills  Bloomberg UK First Country to Approve Merck's COVID-19 Pill  Pharmaceutical Executive Merck says its Covid antiviral treatment less effective than first thought  Financial Times Stocks making the biggest moves midday: Twitter, Moderna, Merck, Tesla and more  CNBC U.K. Set to Deploy Merck's Covid Pill in 10000-Person Study  Bloomberg EU recommends Merck COVID-19 pill for adults at risk of severe illness  Reuters Belgium in talks to buy 10000 doses of Merck's COVID-19 pill, health minister says  Reuters Merck & Co. Inc. stock underperforms Thursday when compared to competitors  MarketWatch Merck Closes Deal for Acceleron Pharma, Biggest Biotech Merger of the Year  Barron's Buffett's Berkshire exited Merck investment just before COVID pill boost, further trimmed AbbVie and BMS holdings  FiercePharma Merck (MRK) Vaxneuvance sBLA for Pediatrics Gets Priority Review  Entrepreneur Pfizer boosts Paxlovid manufacturing capacity as Merck's rival COVID pill hits surprise efficacy setback  FiercePharma Lab worker finds vials labeled ?smallpox? at Merck facility  Fox 56 Pfizer, like Merck, inks deal to license COVID-19 pill and boost global supply  FiercePharma Merck's New Covid Drug Molnupiravir Gets FDA Approval In Time for Omicron  Bloomberg Deutsche Bank : delivers intelligence & automation for Merck India's cross-border cash flows Merck, AstraZeneca's sNDA for breast cancer treatment granted priority review by the FDA  MarketWatch Merck Applies for Covid Pill Approval in Japan, Nikkei Reports Merck's Covid Pill Partner in India Sees a Short-Lived Boom  Bloomberg Merck will support Saudi Arabia effort to build biologics manufacturing operations  FiercePharma What?s Next For Merck Stock After An Upbeat Q3?  Forbes Covid News: U.S. to Tighten Testing for Travelers Amid Omicron Worries  The New York Times Yet another Acceleron investor challenges Merck's $11.5B acquisition offer: Bloomberg  FiercePharma Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference  Business Wire Merck signs strategic agreement with GI Innovation to develop biomedicine  Korea Biomedical Review Merck HIV combo sees approval chances soar to 99%: regulatory roundup  Clinical Trials Arena AHA 2021 ? Merck?s oral cholesterol lowerer could heap more misery on Esperion  Vantage Merck expects Covid pill to reach rich and poor countries simultaneously  FRANCE 24 Merck Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus  Business Wire FDA approves Merck's Keytruda as first immunotherapy for early kidney cancer  BioPharma Dive A worrisome safety signal slows Merck's HIV ambitions  BioPharma Dive Better Buy: Bristol Myers Squibb vs. Merck  Nasdaq Merck, Box Rise Premarket; Salesforce Falls By Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting  Business Wire Italy to acquire 50000 courses for each of Merck, Pfizer COVID-19 antiviral drugs  Reuters German, Austrian authorities approve Merck acquisition of Acceleron  Pharmaceutical Business Review Salesforce, Merck, Cathie Wood, Twitter; Stocks Rebound - 5 Things You Must Know  TheStreet Better COVID Stock: Merck vs. Pfizer  Motley Fool UPDATED: Biogen pulls PRIME designation for aducanumab in Europe; Merck closes merger with Acceleron  Endpoints News Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted  Reuters Here's Why Merck Stock Vaulted Higher in October  The Motley Fool Merck Says It's Working With China to Bring In Its Covid Pill  Bloomberg Merck KGaA's Schistosomiasis Drug Shows Positive Results in Phase-3 Children Trial  MarketWatch Countries rush to buy Merck and Pfizer's experimental COVID-19 pills  Rappler As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea  FierceBiotech Novartis May Have a Suitor for Sandoz; Merck Closes Acceleron Deal  BioSpace Months after a Merck spinout, Organon continues its string of deals with a $954M buyout package  Endpoints News Merck Receives Another Boost for Its Top-Selling Drug  Motley Fool Merck's Plan B Percolates After Pfizer Announces Dominance  Seeking Alpha Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price  MarketWatch Merck signs pact to broaden generic manufacturing of COVID-19 pill  Reuters Merck potential animal health spin could be next after J&J split up  Seeking Alpha Greek American Physician Helped Develop Merck Corona Pill  Greek Reporter The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data  Yahoo Finance Merck COVID-19 pill sparks calls for access for lower income countries  Reuters A new boss, a new path forward and new challenges for N.J. pharma giant The U.K. approves Merck's COVID-19 antiviral pill, calling it a world first  Minnesota Public Radio News How Will Merck's Stock Forecast Be Impacted By U.K.'s COVID Pill Authorization?  Seeking Alpha UK authorizes Merck's coronavirus treatment, the first pill shown to be effective at treating COVID-19  ABC News Merck-Pfizer immunotherapy gets expanded indication for urothelial cancer  Korea Biomedical Review UK approves Merck's COVID pill in world first  Yahoo Singapore News Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths  Reuters COVID-19: Treatments approved in Canada  CTV News Merck to collaborate with Ontada on data-driven cancer insights Merck to buy Acceleron Pharma for $11.5bn  Financial Times Merck on deals hunt as patent cliff looms for top cancer drug  Financial Times Merck, Evidation join forces on Alzheimer's data solutions Pfizer, Merck launch new trials of oral COVID-19 drugs  Reuters Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop  The Guardian What?s Next For Merck Stock After A 5% Fall In A Week?  Forbes Can Merck's new boss maintain the drugmaker's winning streak?  The Economist Merck's Gesture to Save Humanity From COVID-19  Fair Observer U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug  Reuters Merck and Singapore sign deal on COVID-19 antiviral pill  Reuters UK creates deal for 480,000 doses of Merck COVID pill  Open Access Government Merck KGaA, GSK end partnership on former cancer drug hopeful  Reuters A bear and a bull debate the move in health care after Merck?s Covid pill breakthrough  CNBC Merck develops new technology to address solubility and speed to market challenges of ADCs Merck: COVID-related work helped Q1 growth - BioProcess Insider  BioProcess Insider EU Panel May Start Accelerated Review of Merck's Covid Pill  Bloomberg Merck drug less effective against moderate COVID -India regulatory source  Reuters Merck strikes deal for global access to Covid drug  FRANCE 24 Merck taps Xeris for ready-to-use versions of antibody products  FiercePharma Merck to continue tests of Covid pill, but stop trial in hospitalized patients  STAT Merck Sales Beat Estimates, But the Stock Fell. Here?s 1 Reason to Be Bullish.  Barron's Merck, Codexis extend supply deal for key API in Januvia, Janumet  FiercePharma Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds  FiercePharma Merck KGaA says lab supplies business can grow by up to 10% per year  Reuters Merck Announces Appointment of Head of China & International for Healthcare  Business Wire Merck rolls out new lipid technology ahead of schedule Merck KGaA's new CEO shakes up U.S. leadership to spark sales of promising drugs  FiercePharma WHO says seeks more data from Merck on COVID anti-viral, from Bharat on vaccine  Reuters Merck Announces Completion of Organon & Co. Spinoff  Business Wire As Organon charts post-spinoff future, Merck's $9B cash infusion could fund big M&A score  FiercePharma Merck's Welireg scores FDA nod in cancers spurred by rare disease?and its label is broader than expected  FiercePharma Merck begins late-stage trial of experimental COVID-19 drug  Reuters Merck spin-off Organon sees share price jump at Q2 results  PMLiVE
For more news about Merck & Company click here:
Merck & Company News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources